The Association between Reduced Inflammation and Cognitive Gains after Bariatric Surgery

Psychosomatic Medicine

Volumn 77, Issue 6, 2015, Pages 688-696

  Hawkins, Misty A W ^a   Alosco, Michael L ^a   Spitznagel, Mary Beth ^a   Strain, Gladys ^b   Devlin, Michael ^c   Cohen, Ronald ^d   Crosby, Ross D ^e   Mitchell, James E ^e   Gunstad, John ^a  

^a KENT STATE UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

bariatric surgery; C reactive protein; cognitive function; inflammation; obesity; prospective study

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATTENTION; BARIATRIC SURGERY; COGNITION; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION; COGNITION DISORDERS; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; OBESITY; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ATTENTION; BARIATRIC SURGERY; C-REACTIVE PROTEIN; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; TREATMENT OUTCOME;

EID: 84936993722     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000125     Document Type: Article

References (66)

1. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL,. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998; 22: 39-47.
2. Flegal KM, Carroll MD, Kit BK, Ogden CL,. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-7.
3. World Health Organization. Obesity Situation and Trends. Global Health Observatory. 2013. Available at: http://www.who.int/gho/ncd/risk-factors/obesity-text/en/index.html. Accessed August 17, 2013.
4. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
5. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH,. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-9.
6. Ferraro KF, Su YP, Gretebeck RJ, Black DR, Badylak SF,. Body mass index and disability in adulthood: a 20-year panel study. Am J Public Health 2002; 92: 834-40.
7. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, Committee obotAHAS, Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-215.
8. Smith E, Hay P, Campbell L, Trollor J,. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev 2011; 12: 740-55.
9. Cournot M, Marquie J, Ansiau D, Martinaud C, Fonds H, Ferrieres J, Ruidavets J,. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006; 67: 1208-14.
10. Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E,. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry 2007; 48: 57-61.
11. Gunstad J, Lhotsky A, Wendell CR, Ferrucci L, Zonderman AB,. Longitudinal examination of obesity and cognitive function: results from the Baltimore Longitudinal Study of Aging. Neuroepidemiology 2010; 34: 222-9.
12. Stanek KM, Strain G, Devlin M, Cohen R, Paul R, Crosby RD, Mitchell JE, Gunstad J,. Body mass index and neurocognitive functioning across the adult lifespan. Neuropsychology 2013; 27: 141.
13. Beydoun M, Beydoun H, Wang Y,. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9: 204-18.
14. Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Grieve S, Gordon E,. Relationship between body mass index and brain volume in healthy adults. Int J Neurosci 2008; 118: 1582-93.
15. Alosco ML, Spitznagel MB, Strain G, Devlin M, Cohen R, Paul R, Crosby RD, Mitchell JE, Gunstad J,. Improved memory function two years after bariatric surgery. Obesity 2014; 22: 32-8.
16. Miller LA, Crosby RD, Galioto R, Strain G, Devlin MJ, Wing R, Cohen RA, Paul RH, Mitchell JE, Gunstad J,. Bariatric surgery patients exhibit improved memory function 12 months postoperatively. Obes Surg 2013; 23: 1527-35.
17. Holz T, Thorand B, Döring A, Schneider A, Meisinger C, Koenig W,. Markers of inflammation and weight change in middle-aged adults: results from the prospective MONICA/KORA S3/F3 study. Obesity 2010; 18: 2347-53.
18. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G, for the AI. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults-the ARIC study. Obes Res 2000; 8: 279-86.
19. Cancello R, Clement K,. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. Int J Obstet Gynaecol 2006; 113: 1141-7.
20. Choi J, Joseph L, Pilote L,. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013; 14: 232-44.
21. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C,. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005; 183: 308-15.
22. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau J, Bastard J,. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα leptin and IL-6 levels in obese women. Int J Obes 2004; 28: 993-7.
23. Park HS, Park JY, Yu R,. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabet Res Clin Pract 2005; 69: 29-35.
24. Gorelick PB,. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci 2010; 1207: 155-62.
25. Trollor JN, Smith E, Agars E, Kuan SA, Baune BT, Campbell L, Samaras K, Crawford J, Lux O, Kochan NA,. The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age 2012; 34: 1295-308.
26. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB,. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237.
27. Yaffe K, Lindquist K, Penninx B, Simonsick E, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T,. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61: 76-80.
28. Dik M, Jonker C, Hack C, Smit J, Comijs H, Eikelenboom P,. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005; 64: 1371-7.
29. Misiak B, Leszek J, Kiejna A,. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease-the emerging role of systemic low-grade inflammation and adiposity. Brain Res Bull 2012; 89: 144-9.
30. Ramos EJ, Xu Y, Romanova I, Middleton F, Chen C, Quinn R, Inui A, Das U, Meguid MM,. Is obesity an inflammatory disease? Surgery 2003; 134: 329-35.
31. Ghanim H, Monte SV, Sia CL, Abuaysheh S, Green K, Caruana JA, Dandona P,. Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab 2012; 97: E1197-201.
32. Belle SH, Berk PD, Courcoulas AP, Flum DR, Miles CW, Mitchell JE, Pories WJ, Wolfe BM, Yanovski SZ,. Safety and efficacy of bariatric surgery: longitudinal assessment of bariatric surgery. Surg Obes Relat Dis 2007; 3: 116-26.
33. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL,. Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003; 107: 499-511.
34. Paul RH, Lawrence J, Williams LM, RICHARD CC, Cooper N, Gordon E,. Preliminary validity of "integneuroTM": a new computerized battery of neurocognitive tests. Int J Neurosci 2005; 115: 1549-67.
35. Williams L, Simms E, Clark C, Paul R, Rowe D, Gordon E,. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker." Int J Neurosci 2005; 115: 1605-30.
36. Reitan RM,. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-6.
37. Golden JC,. Stroop Color and Word Test. Stoelting: Chicago, IL; 1978.
38. Mertler CA,. Interpreting Standardized Test Scores: Strategies for Data-Driven Instructional Decision Making. Thousand Oaks, CA: Sage Publications, Inc.; 2007.
39. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, Deacon RM, Rawlins JNP, Perry VH,. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 2009; 65: 304-12.
40. Marsland AL, Petersen KL, Sathanoori R, Muldoon MF, Neumann SA, Ryan C, Flory JD, Manuck SB,. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 2006; 68: 895-903.
41. Teunissen C, Van Boxtel M, Bosma H, Bosmans E, Delanghe J, De Bruijn C, Wauters A, Maes M, Jolles J, Steinbusch H,. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 2003; 134: 142-50.
42. Gimeno D, Marmot MG, Singh-Manoux A,. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 2008; 33: 1322-34.
43. Mooijaart SP, Sattar N, Trompet S, Lucke J, Stott DJ, Ford I, Jukema J, Westendorp RG, Craen AJ,. Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J Intern Med 2013; 274: 77-85.
44. Lappegård KT, Pop-Purceleanu M, van Heerde W, Sexton J, Tendolkar I, Pop G,. Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy. Dementia 2013; 11: 16.
45. Gumbs AA, Modlin IM, Ballantyne GH,. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15: 462-73.
46. Tuulari JJ, Karlsson HK, Hirvonen J, Hannukainen JC, Bucci M, Helmiö M, Ovaska J, Soinio M, Salminen P, Savisto N,. Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese. Diabetes 2013; 62: 2747-51.
47. Convit A,. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiology of aging 2005; 26: 31-5.
48. Athyros V, Tziomalos K, Karagiannis A, Mikhailidis D,. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obes Rev 2011; 12: 515-24.
49. Hillman CH, Erickson KI, Kramer AF,. Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci 2008; 9: 58-65.
50. Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin J-M, Lecompte T, Lacolley P, Benetos A, Zannad F,. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40: 1229-36.
51. Vázquez LA, Pazos F, Berrazueta JR, Fernández-Escalante C, García-Unzueta MT, Freijanes J, Amado JA,. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005; 90: 316-22.
52. Reizes O, Benoit SC, Clegg DJ,. Neuroregulation of appetite. In: Kushner RF, Bessesen DH, editors. Treatment of the Obese Patient. Totowa, NJ: Humana Press; 2007; 3-26.
53. Redrobe JP, Dumont Y, St-Pierre J-A, Quirion R,. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res 1999; 848: 153-66.
54. Bennett G, Ballard T, Watson C, Fone K,. Effect of neuropeptides on cognitive function. Exp Gerontol 1997; 32: 451-69.
55. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR,. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108.
56. Barnes DE, Yaffe K,. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011; 10: 819-28.
57. Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R,. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)-a prospective study. Obes Surg 2010; 20: 447-53.
58. Langer F, Hoda MR, Bohdjalian A, Felberbauer F, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G,. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024-9.
59. Santry HP, Gillen DL, Lauderdale DS,. Trends in bariatric surgical procedures. JAMA 2005; 294: 1909-17.
60. Barnes DE, Yaffe K, Satariano WA, Tager IB,. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc 2003; 51: 459-65.
61. McAuley E, Mullen SP, Hillman CH,. Physical Activity, Cardiorespiratory Fitness, and Cognition Across the Lifespan. In: Hall PA, editor. Social Neuroscience and Public Health. New York: Springer; 2013: 235-52.
62. Lavie CJ, Church TS, Milani RV, Earnest CP,. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 2011; 31: 137-45.
63. Kasapis C, Thompson PD,. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005; 45: 1563-9.
64. Amado-Boccara I, Gougoulis N, Poirier Littre M, Galinowski A, Loo H,. Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 1995; 19: 479-93.
65. Muldoon MF, Waldstein SR, Ryan CM, Jennings JR, Polefrone JM, Shapiro AP, Manuck SB,. Effects of six anti-hypertensive medications on cognitive performance. J Hypertens 2002; 20: 1643-52.
66. Golomb BA, Criqui MH, White H, Dimsdale JE,. Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Arch Intern Med 2004; 164: 153-62.